CNLM Virtual Colloquium Series

(Re) Defining Myeloid Cell States
and Function in Alzheimer’s Disease

Dr. Beth Stevens

Tuesday, Feb. 9, 2021
11 a.m. - 12 p.m. PST

Beth Stevens, Ph.D.
Boston Children's Hospital, F.M. Kirby Neurobiology Center
Harvard University

Those who register will receive an email with information on accessing the Zoom meeting the morning of the event. Sign up for other talks on our website:

cnlm.uci.edu/colloquium-series

 

Event Description:

Emerging evidence from genetic association studies shows that dysregulation of the brain’s immune system plays a key role in the onset and progression of neurodegenerative disease. Our research aims to identify and validate disease mechanisms informed by human genetics and identify functional and mechanistic markers of myeloid and glial cells in detrimental states, before cognitive decline, that can be readily detected through imaging and fluid biomarkers. Using single-cell RNA sequencing, spatial transcriptomics and proteomic approaches we identified molecular signatures that can be used to localize and monitor distinct microglia functional states in human and mouse brain. Our results show that microglia assume diverse functional states in development, aging and injury, including populations corresponding to known microglial functions including proliferation, migration, inflammation, and synaptic phagocytosis. In addition, we identified several innate immune pathways by which microglia recognize and prune synapses during development and in models of disease, including the classical complement cascade. Illuminating the mechanisms by which developing synaptic circuits are sculpted is providing important insight on understanding how to protect synapses in Alzheimer’s and other neurodegenerative diseases of synaptic dysfunction.

Invite Your Colleagues

This year, we are opening up registration for the CNLM Colloquium Series to researchers from the broader learning and memory scientific community.